AAM
AGN

Aureus Asset Management’s Allergan Inc AGN Stock Holding History

Aureus Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,426
Closed -$1.79M – 166
2014
Q4 		$1.79M Sell
8,426
-329
-4% -$65.4K 0.44% 49
2014
Q3 		$1.56M Sell
8,755
-10,510
-55% -$1.75M 0.39% 48
2014
Q2 		$3.26M Sell
19,265
-38,719
-67% -$6.03M 0.82% 43
2014
Q1 		$7.2M Sell
57,984
-2,701
-4% -$329K 1.85% 22
2013
Q4 		$6.74M Buy
60,685
+9,850
+19% +$941K 1.83% 23
2013
Q3 		$4.6M Buy
50,835
+7,690
+18% +$690K 1.57% 33
2013
Q2 		$3.63M Buy
+43,145
New +$4.48M 1.3% 37

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Aureus Asset Management's AGN Position: Q1 2015 in Review

Aureus Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,426 shares — an estimated $1.79M sold.

Aureus Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.2M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Aureus Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Aureus Asset Management sold 8,426 Allergan Inc shares in Q1 2015, an estimated $1.79M.
  • Aureus Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Aureus Asset Management's Allergan Inc position peaked at $7.2M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Aureus Asset Management's 13F filing for Q1 2015, filed 13 May 2015.